Citigroup’s Outlook Therapeutics OTLK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.5K | Sell |
17,199
-561
| -3% | -$898 | ﹤0.01% | 4271 |
|
|
2025
Q1 | $21.7K | Buy |
17,760
+2,731
| +18% | +$3.33K | ﹤0.01% | 4307 |
|
|
2024
Q4 | $28.4K | Buy |
15,029
+2,693
| +22% | +$5.09K | ﹤0.01% | 4365 |
|
|
2024
Q3 | $65.9K | Buy |
12,336
+10,003
| +429% | +$53.4K | ﹤0.01% | 4156 |
|
|
2024
Q2 | $17.2K | Buy |
2,333
+778
| +50% | +$5.74K | ﹤0.01% | 4300 |
|
|
2024
Q1 | $18.6K | Buy |
1,555
+341
| +28% | +$4.07K | ﹤0.01% | 4300 |
|
|
2023
Q4 | $9.57K | Buy |
1,214
+1,200
| +8,571% | +$9.46K | ﹤0.01% | 4440 |
|
|
2023
Q3 | $64 | Sell |
14
-2,296
| -99% | -$10.5K | ﹤0.01% | 4730 |
|
|
2023
Q2 | $80.4K | Buy |
+2,310
| New | +$80.4K | ﹤0.01% | 3680 |
|
|
2023
Q1 | – | Sell |
-40
| Closed | -$862 | – | 4870 |
|
|
2022
Q4 | $862 | Sell |
40
-50
| -56% | -$1.08K | ﹤0.01% | 4637 |
|
|
2022
Q3 | $2K | Sell |
90
-298
| -77% | -$6.62K | ﹤0.01% | 4708 |
|
|
2022
Q2 | $8K | Buy |
388
+183
| +89% | +$3.77K | ﹤0.01% | 4705 |
|
|
2022
Q1 | $7K | Sell |
205
-942
| -82% | -$32.2K | ﹤0.01% | 4897 |
|
|
2021
Q4 | $31K | Buy |
1,147
+575
| +101% | +$15.5K | ﹤0.01% | 4488 |
|
|
2021
Q3 | $25K | Buy |
572
+364
| +175% | +$15.9K | ﹤0.01% | 4381 |
|
|
2021
Q2 | $10K | Buy |
+208
| New | +$10K | ﹤0.01% | 4987 |
|